Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus

International Journal of Prisoner Health

Volumn 4, Issue 2, 2008, Pages 77-82

  Pontali, Emanuele ^a   Ferrari, Franco ^a  

^a Prison of Genoa   (Italy)

Author keywords

Hepatitis B; Hepatitis C; HIV

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS RNA;

ARTICLE; COMORBIDITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRISON; PRISONER; VIRUS DIAGNOSIS; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MASS SCREENING; PROSPECTIVE STUDY; STATISTICS; SUBSTANCE ABUSE; VIROLOGY;

CHI-SQUARE DISTRIBUTION; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; ITALY; MALE; MASS SCREENING; PREVALENCE; PRISONERS; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 44949177525     PISSN: 17449200     EISSN: 17449219     Source Type: Journal    
DOI: 10.1080/17449200802038207     Document Type: Article

References (20)

1. Adjei, A.A., Armah, H.B., Gbagbo, F., Ampofo, W.K., Quaye, I.K.E., Hesse, I.F.A., et al. (2006). Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. Journal of Medical Microbiology, 55, 593-597.
2. Babudieri, S., Starnini, G., Brunetti, B., Carbonara, S., D'Offizi, G.P., Monarca, R., et al. (2003). HIV e infezioni correlate negli Istituti Penitenziari Italiani: note di epidemiologia e di organizzazione sanitaria. Ann Ist Super Sanità, 39, 251-257.
3. Babudieri, S., Longo, B., Sarmati, L., Starnini, G., Dori, L.B., Carbonara, S., et al. (2005). Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy. Journal of Medical Virology, 76, 311-317.
4. Benhamou, Y. (2006). Treatment algorithm for chronic hepatitis B in HIV-infected patients. Journal of Hepatology, 44 (suppl. 1), 90-94.
5. Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., et al. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 32, 492-497.
6. Butler, T., Boonwaat, L., Hailstone, S., Falconer, T., Lems, P., Ginley, T., et al. (2007). The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Australia and New Zealand Journal of Public Health, 31, 44-50.
7. Department of Health and Human Services (DHHS). Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Retrieved 10 October 2006, from: (http://AIDSinfo.nih.gov).
8. Filippini, P., Coppola, N., Pisapia, R., Scolastico, C., Marrocco, C., Zaccariello, A., Nacca, C., et al. (2006). Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. AIDS, 20, 1253-1260.
9. French, M.A., Price, P., & Stone, S.F. (2004). Immune restoration disease after antiretroviral therapy. AIDS, 18, 1615-1628.
10. Graham, C., Baden, L., Yu, E., Mrus, J.M., Carnie, J., Heeren, T., et al. (2001). Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clinical Infectious Diseases, 33, 562-569.
11. Jürgens, R., & Bijl, M. (2001). HIV prevention in penal institutions. Chapter 5. In: WHO-EURO. HIV in prisons. A reader with particular relevance to the newly independent states. Copenhagen, Danmark.
12. Marcellin, P., Asselah, T., & Boyer, N. (2005). Treatment of chronic hepatitis B. Journal of Viral Hepatology, 12, 333-345.
13. McGovern, B., Fiore, J., Wurcel, A., Taglienti, P., Bradley, M., Galvin, S., et al. (2005). Delivering therapy for Hepatitis C virus infection to incarcerated HIV-seropositive patients. Clinical Infectious Diseases, 41 (suppl. 1), 56-62.
14. Shire, N.J., Rouster, S.D., Rajicic, N., & Sherman, K.E. (2004). Occult hepatitis B in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome, 36, 869-875.
15. Soriano, V. (2006). Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates. Journal of Hepatology, 44 (1 Suppl.), S44-48.
16. Spaulding, A.C., Lally, M., Rich, J.D., & Dieterich, D.T. (1999). Hepatitis B and C in the context of HIV disease: A review, with an emphasis on implications for incarcerated populations. AIDS Reader, 9, 481-491.
17. Torriani, F.J., Rodriguez-Torres, M., Rockstroh, J.K., Lissen, E., Gonzalez-Garcia, J., Lazzarin, A., et al. (2004). Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine, 351, 438-450.
18. Weild, A.R., Gill, O.N., Bennett, D., Livingstone, S.J., Parry, J.V., & Curran, L. (2000). Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: A national survey. Community, Disease and Public Health, 3, 121-126.
19. Weinbaum, C.M., Sabin, K.M., & Santibanez, S.S. (2005). Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS, 19 (suppl. 3), 41-46.
20. Wilson, D., Ford, N., Ngammee, V., Chua, A., & Kyaw Kyaw, M. (2007) HIV prevention, care, and treatment in two prisons in Thailand. PLoS Med, 4(6), e204. doi:10.1371/journal.pmed.0040204